Articles tagged with “semaglutide”

The ePA Process for GLP-1 Drugs: A Workflow Guide

Explore the electronic prior authorization (ePA) workflow for GLP-1 drugs. Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges.

65 min read

11/12/2025

glp-1 drugs prior authorization process semaglutide ncpdp script medication access health it

Pharmacy vs. Medical Benefit Explained: GLP-1 Coverage

Learn the key differences between pharmacy vs. medical benefit and how this structure impacts insurance coverage for GLP-1 drugs for diabetes and obesity, including the 2025–2026 Medicare BALANCE Model, manufacturer price cuts, and employer coverage trends.

50 min read

11/7/2025

pharmacy benefit medical benefit glp-1 coverage semaglutide insurance benefits drug formulary pbm healthcare policy specialty drugs

GLP-1 Drugs: A Complete History of Incretin-Based Therapy

Learn the complete history of GLP-1 drugs from the incretin effect to 2026 breakthroughs. Covers exenatide, semaglutide, tirzepatide, oral Wegovy, retatrutide, CagriSema, and the evolution from diabetes to obesity treatment.

70 min read

11/2/2025

glp-1 agonist incretin effect history of medicine diabetes treatment obesity medication semaglutide exenatide endocrinology